Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells
We investigated various combination treatment regimens employing nilotinib with established chemotherapeutic agents (daunorubicin, mitoxantrone, etoposide and cytarabine) in imatinib-sensitive and -resistant BCR-ABL-positive cells. Mitoxantrone or cytarabine showed synergism (CI < 1) in combinati...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2010
|
| In: |
Cancer chemotherapy and pharmacology
Year: 2010, Volume: 66, Issue: 2, Pages: 255-264 |
| ISSN: | 1432-0843 |
| DOI: | 10.1007/s00280-009-1158-7 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00280-009-1158-7
|
| Author Notes: | Aleksandar Radujkovic, Stefan Fruehauf, W. Jens Zeller, Anthony D. Ho, Julian Topaly |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1844879313 | ||
| 003 | DE-627 | ||
| 005 | 20240327080249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230509s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00280-009-1158-7 |2 doi | |
| 035 | |a (DE-627)1844879313 | ||
| 035 | |a (DE-599)KXP1844879313 | ||
| 035 | |a (OCoLC)1389805796 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Radujković, Aleksandar |d 1980- |e VerfasserIn |0 (DE-588)132951320 |0 (DE-627)529183536 |0 (DE-576)299523721 |4 aut | |
| 245 | 1 | 0 | |a Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells |c Aleksandar Radujkovic, Stefan Fruehauf, W. Jens Zeller, Anthony D. Ho, Julian Topaly |
| 264 | 1 | |c 2010 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 28. Oktober 2009 | ||
| 500 | |a Gesehen am 09.05.2023 | ||
| 520 | |a We investigated various combination treatment regimens employing nilotinib with established chemotherapeutic agents (daunorubicin, mitoxantrone, etoposide and cytarabine) in imatinib-sensitive and -resistant BCR-ABL-positive cells. Mitoxantrone or cytarabine showed synergism (CI < 1) in combination with nilotinib in imatinib-sensitive LAMA84 cells, whereas in imatinib-resistant LAMA84-R cells synergistic effects could be assessed for daunorubicin, mitoxantrone and etoposide when combined with nilotinib. In both imatinib-sensitive and -resistant K562 cells daunorubicin, mitoxantrone and etoposide demonstrated synergism in combination with nilotinib. Moreover, both daunorubicin and mitoxantrone led to synergistic antiproliferative effects when combined with nilotinib in imatinib-resistant Ba/F3 cells carrying point mutations in the ABL TK domain (E255K, E255V and T315I). Annexin V/propidium iodide staining revealed a significant enhancement of nilotinib-induced apoptosis in imatinib-resistant Ba/F3T315I and LAMA84-R cells upon combination with daunorubicin and mitoxantrone, respectively. Our results demonstrate the efficacy of combination treatment regimens employing nilotinib and established chemotherapeutic agents in improving antileukemic effects in imatinib-sensitive and imatinib-resistant cells. This may be the foundation for further study on the potential of the applied combinations in a clinical setting. | ||
| 650 | 4 | |a BCR-ABL | |
| 650 | 4 | |a Combination treatment | |
| 650 | 4 | |a Imatinib resistance | |
| 650 | 4 | |a Nilotinib | |
| 650 | 4 | |a Synergism | |
| 700 | 1 | |a Fruehauf, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zeller, W. Jens |d 1944- |e VerfasserIn |0 (DE-588)1114851868 |0 (DE-627)86925524X |0 (DE-576)168963582 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Topaly, Julian |d 1973- |e VerfasserIn |0 (DE-588)124381383 |0 (DE-627)363308237 |0 (DE-576)294146563 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer chemotherapy and pharmacology |d Berlin : Springer, 1978 |g 66(2010), 2, Seite 255-264 |h Online-Ressource |w (DE-627)253390435 |w (DE-600)1458488-8 |w (DE-576)072283467 |x 1432-0843 |7 nnas |a Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells |
| 773 | 1 | 8 | |g volume:66 |g year:2010 |g number:2 |g pages:255-264 |g extent:10 |a Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00280-009-1158-7 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230509 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 124381383 |a Topaly, Julian |m 124381383:Topaly, Julian |d 50000 |e 50000PT124381383 |k 0/50000/ |p 5 |y j | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1114851868 |a Zeller, W. Jens |m 1114851868:Zeller, W. Jens |d 50000 |e 50000PZ1114851868 |k 0/50000/ |p 3 | ||
| 998 | |g 132951320 |a Radujković, Aleksandar |m 132951320:Radujković, Aleksandar |d 910000 |d 910100 |e 910000PR132951320 |e 910100PR132951320 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1844879313 |e 4320018192 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells","title_sort":"Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells"}],"note":["Online veröffentlicht: 28. Oktober 2009","Gesehen am 09.05.2023"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"disp":"Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cellsCancer chemotherapy and pharmacology","id":{"zdb":["1458488-8"],"issn":["1432-0843"],"eki":["253390435"]},"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 38.1996: Supplement"],"titleAlt":[{"title":"CCP"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1978-","publisher":"Springer","dateIssuedKey":"1978","publisherPlace":"Berlin ; Heidelberg"}],"recId":"253390435","title":[{"title_sort":"Cancer chemotherapy and pharmacology","title":"Cancer chemotherapy and pharmacology","subtitle":"CCP"}],"part":{"year":"2010","text":"66(2010), 2, Seite 255-264","volume":"66","issue":"2","pages":"255-264","extent":"10"},"language":["eng"],"pubHistory":["1.1978 -"]}],"id":{"eki":["1844879313"],"doi":["10.1007/s00280-009-1158-7"]},"physDesc":[{"extent":"10 S."}],"recId":"1844879313","origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Radujković, Aleksandar","given":"Aleksandar","role":"aut","family":"Radujković"},{"family":"Fruehauf","given":"Stefan","role":"aut","display":"Fruehauf, Stefan"},{"display":"Zeller, W. Jens","role":"aut","given":"W. Jens","family":"Zeller"},{"family":"Ho","display":"Ho, Anthony Dick","given":"Anthony Dick","role":"aut"},{"role":"aut","given":"Julian","display":"Topaly, Julian","family":"Topaly"}],"name":{"displayForm":["Aleksandar Radujkovic, Stefan Fruehauf, W. Jens Zeller, Anthony D. Ho, Julian Topaly"]}} | ||
| SRT | |a RADUJKOVICSYNERGISTI2010 | ||